ProfiLER investigators. Molecular Screening Program to Select Molecular-Based Recommended Therapies for Metastatic Cancer Patients: Analysis from the ProfiLER Trial - Trédan, O; Wang, Q; Pissaloux, D; Cassier, P; de la Fouchardière, A; Fayette, J; Desseigne, F; Ray-Coquard, I; de la Fouchardière, C; Frappaz, D; Heudel, P-E; Bonneville-Levard, A; Fléchon, A; Sarabi, M; Guibert, P; Bachelot, T; Pérol, M; You, B; Bonnin, N; Collard, O; Leyronnas, C; Attignon, V; Baudet, C; Sohier, E; Villemin, J-P; Viari, A; Boyault, S; Lantuejoul, S; Paindavoine, S; Treillleux, I; Rodriguez, C; Agrapart, V; Corset, V; Garin, G; Chabaud, S; Pérol, D; Blay, J-Y (Ann Oncol Off J Eur Soc Med Oncol, 2019)